DK3548092T3 - Rmp-sammensætning og fremgangsmåder til anvendelse deraf - Google Patents
Rmp-sammensætning og fremgangsmåder til anvendelse deraf Download PDFInfo
- Publication number
- DK3548092T3 DK3548092T3 DK17876484.1T DK17876484T DK3548092T3 DK 3548092 T3 DK3548092 T3 DK 3548092T3 DK 17876484 T DK17876484 T DK 17876484T DK 3548092 T3 DK3548092 T3 DK 3548092T3
- Authority
- DK
- Denmark
- Prior art keywords
- rmp
- composition
- methods
- rmp composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/19—Platelets; Megacaryocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662428155P | 2016-11-30 | 2016-11-30 | |
| PCT/US2017/063700 WO2018102409A2 (en) | 2016-11-30 | 2017-11-29 | Rmp composition and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3548092T3 true DK3548092T3 (da) | 2022-08-01 |
Family
ID=62241842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17876484.1T DK3548092T3 (da) | 2016-11-30 | 2017-11-29 | Rmp-sammensætning og fremgangsmåder til anvendelse deraf |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11241457B2 (da) |
| EP (1) | EP3548092B1 (da) |
| JP (2) | JP2020508963A (da) |
| KR (2) | KR20190099436A (da) |
| CN (1) | CN110799199B (da) |
| AU (1) | AU2017367084B2 (da) |
| BR (1) | BR112019010981A2 (da) |
| CA (1) | CA3045144A1 (da) |
| DK (1) | DK3548092T3 (da) |
| ES (1) | ES2924134T3 (da) |
| HR (1) | HRP20220892T1 (da) |
| HU (1) | HUE059678T2 (da) |
| IL (1) | IL266957B (da) |
| LT (1) | LT3548092T (da) |
| MX (1) | MX2019006354A (da) |
| PL (1) | PL3548092T3 (da) |
| PT (1) | PT3548092T (da) |
| RS (1) | RS63537B1 (da) |
| RU (1) | RU2768743C2 (da) |
| SI (1) | SI3548092T1 (da) |
| WO (1) | WO2018102409A2 (da) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4529561A (en) | 1978-03-24 | 1985-07-16 | The Regents Of The University Of California | Method for producing liposomes in selected size range |
| US5332578A (en) | 1989-04-14 | 1994-07-26 | Prp, Inc. | Platelet membrane microparticles |
| HUT75656A (en) * | 1994-02-14 | 1997-05-28 | Kirin Brewery | Protein having tpo activity |
| US5690963A (en) | 1995-06-30 | 1997-11-25 | The United States Of America As Represented By The Secretary Of The Navy | Freeze dried red blood cells |
| DE69941031D1 (de) | 1998-11-12 | 2009-08-06 | Novolytics Inc | Zusammensetzungen und verfahren zur erzeugung von gefässeokklusion |
| US20030040480A1 (en) | 2001-07-20 | 2003-02-27 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides |
| US7294455B2 (en) * | 2003-05-16 | 2007-11-13 | The University Of North Carolina At Chapel Hill | Fixed-dried platelets cross-linked to protein |
| US7811558B2 (en) | 2004-08-12 | 2010-10-12 | Cellphire, Inc. | Use of stabilized platelets as hemostatic agent |
| US9155764B1 (en) * | 2004-12-07 | 2015-10-13 | University Of Miami | Expanded utility of red-cell derived microparticles (RMP) for treatment of bleeding |
| JP5204490B2 (ja) | 2004-12-07 | 2013-06-05 | ユニバーシティー オブ マイアミ | 出血の制御及び出血性疾患の治療のための止血剤としての細胞由来微粒子 |
| US20080057505A1 (en) | 2006-07-14 | 2008-03-06 | Ping Lin | Methods and compositions for detecting rare cells from a biological sample |
| HUE038138T2 (hu) * | 2011-01-28 | 2018-09-28 | Univ Miami | Vörösvértestbõl származó mikrorészecskék (RMP) kiterjesztett alkalmazása vérzés kezelésére |
| WO2015069897A1 (en) | 2013-11-07 | 2015-05-14 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Red blood cell membrane-derived microparticles and their use for the treatment of lung disease |
| EP3265116B1 (en) | 2015-03-04 | 2021-06-02 | University of Rochester | Systemic and topical application of platelet microparticles to treat bleeding in trauma patients |
-
2017
- 2017-11-29 HU HUE17876484A patent/HUE059678T2/hu unknown
- 2017-11-29 CN CN201780074200.3A patent/CN110799199B/zh active Active
- 2017-11-29 SI SI201731199T patent/SI3548092T1/sl unknown
- 2017-11-29 LT LTEPPCT/US2017/063700T patent/LT3548092T/lt unknown
- 2017-11-29 ES ES17876484T patent/ES2924134T3/es active Active
- 2017-11-29 PT PT178764841T patent/PT3548092T/pt unknown
- 2017-11-29 HR HRP20220892TT patent/HRP20220892T1/hr unknown
- 2017-11-29 EP EP17876484.1A patent/EP3548092B1/en active Active
- 2017-11-29 JP JP2019529843A patent/JP2020508963A/ja active Pending
- 2017-11-29 CA CA3045144A patent/CA3045144A1/en active Pending
- 2017-11-29 RS RS20220717A patent/RS63537B1/sr unknown
- 2017-11-29 KR KR1020197018762A patent/KR20190099436A/ko not_active IP Right Cessation
- 2017-11-29 AU AU2017367084A patent/AU2017367084B2/en active Active
- 2017-11-29 WO PCT/US2017/063700 patent/WO2018102409A2/en unknown
- 2017-11-29 DK DK17876484.1T patent/DK3548092T3/da active
- 2017-11-29 RU RU2019120008A patent/RU2768743C2/ru active
- 2017-11-29 MX MX2019006354A patent/MX2019006354A/es unknown
- 2017-11-29 BR BR112019010981A patent/BR112019010981A2/pt unknown
- 2017-11-29 US US16/465,054 patent/US11241457B2/en active Active
- 2017-11-29 KR KR1020247007757A patent/KR20240049569A/ko active Search and Examination
- 2017-11-29 PL PL17876484.1T patent/PL3548092T3/pl unknown
-
2019
- 2019-05-28 IL IL266957A patent/IL266957B/en unknown
-
2022
- 2022-10-28 JP JP2022173557A patent/JP2023017857A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2019120008A (ru) | 2021-01-13 |
| LT3548092T (lt) | 2022-10-10 |
| RU2768743C2 (ru) | 2022-03-24 |
| US11241457B2 (en) | 2022-02-08 |
| AU2017367084B2 (en) | 2023-11-23 |
| EP3548092B1 (en) | 2022-07-06 |
| PT3548092T (pt) | 2022-08-09 |
| MX2019006354A (es) | 2019-10-21 |
| IL266957B (en) | 2022-05-01 |
| JP2020508963A (ja) | 2020-03-26 |
| EP3548092A4 (en) | 2021-01-27 |
| HUE059678T2 (hu) | 2022-12-28 |
| IL266957A (en) | 2019-07-31 |
| KR20240049569A (ko) | 2024-04-16 |
| AU2017367084A1 (en) | 2019-06-20 |
| KR20190099436A (ko) | 2019-08-27 |
| EP3548092A2 (en) | 2019-10-09 |
| US20190321406A1 (en) | 2019-10-24 |
| RS63537B1 (sr) | 2022-09-30 |
| RU2019120008A3 (da) | 2021-03-09 |
| JP2023017857A (ja) | 2023-02-07 |
| ES2924134T3 (es) | 2022-10-04 |
| PL3548092T3 (pl) | 2022-10-10 |
| WO2018102409A2 (en) | 2018-06-07 |
| CN110799199B (zh) | 2024-01-30 |
| WO2018102409A3 (en) | 2019-12-05 |
| HRP20220892T1 (hr) | 2022-10-14 |
| CN110799199A (zh) | 2020-02-14 |
| SI3548092T1 (sl) | 2022-10-28 |
| BR112019010981A2 (pt) | 2019-10-15 |
| CA3045144A1 (en) | 2018-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3234133T3 (da) | Crispr-baserede sammensætninger og fremgangsmåder til anvendelse | |
| DK3298043T3 (da) | SIRP-polypeptidsammensætninger og fremgangsmåder til anvendelse | |
| DK3453707T3 (da) | Benzazepinderivat, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3259597T3 (da) | Pvrig-polypeptider og fremgangsmåder til behandling | |
| DK3653221T3 (da) | Anti-pvrig-antistoffer og anvendelsesfremgangsmåder | |
| DK3215532T3 (da) | Anti-TIM3-antistoffer og fremgangsmåder til anvendelse | |
| DK3529257T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3557998T3 (da) | Sammensætninger, kompositioner og anvendelsesmetoder | |
| DK3377612T3 (da) | Funktionel ekspression af monooxygenaser og fremgangsmåder til anvendelse | |
| DK3240895T3 (da) | Sammensætninger og fremgangsmåder til proteinglykosylering | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
| DK3144001T3 (da) | Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf | |
| DK3250610T3 (da) | Fcrn-antistoffer og fremgangsmåder til anvendelse heraf | |
| DK3271347T3 (da) | Antifungale forbindelser og fremstillingsfremgangsmåder | |
| DK3551209T3 (da) | Insulin-fc-fusioner og fremgangsmåder til anvendelse | |
| DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
| DK3368578T3 (da) | Anti-HtrA1-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3194564T3 (da) | Trichodermasammensætninger og anvendelsesfremgangsmåder | |
| DK3178324T3 (da) | Mikrobicid og fremgangsmåde til fremstilling af samme | |
| DK3178980T3 (da) | Stof og fremgangsmåde til stoffremstilling | |
| DK3089971T3 (da) | Forbindelser og fremgangsmåder til anvendelse | |
| DK3261644T3 (da) | Sammensætninger og fremgangsmåder til behandling af nethindenedbrydning |